-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EzJeiS095UU+ChMOMulN7PGq1p25Uux/qOpfZDUTTpUWYSGk8YMhJB92u4skcfiQ NNDD7/GVfxXrMzwNQZCybw== 0000950135-00-000865.txt : 20000216 0000950135-00-000865.hdr.sgml : 20000216 ACCESSION NUMBER: 0000950135-00-000865 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000215 GROUP MEMBERS: ADVENT HEALTH CARE & LIFE SCIENCES II BETEILIGUNG GROUP MEMBERS: ADVENT HEALTH CARE & LIFE SCIENCES II LTD GROUP MEMBERS: ADVENT HEALTH CARE & LIFE SCIENCES II VERWALTUNGS GROUP MEMBERS: ADVENT INT'L INVESTORS II LTD GROUP MEMBERS: ADVENT INT'L LTD GROUP MEMBERS: ADVENT INTERNATIONAL CORP ET AL GROUP MEMBERS: ADVENT PARTNERS HLS LTD GROUP MEMBERS: ADVENT PARTNERS LTD GROUP MEMBERS: ADVENT PERFORMANCE MATERIALS LTD GROUP MEMBERS: ADVENTACT LTD GROUP MEMBERS: ROVENT II LTD SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ILEX ONCOLOGY INC CENTRAL INDEX KEY: 0001001915 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 742699185 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-53221 FILM NUMBER: 544910 BUSINESS ADDRESS: STREET 1: 11550 IH-10 WEST SUITE 300 CITY: SAN ANTONIO STATE: TX ZIP: 78230 BUSINESS PHONE: 2106776080 MAIL ADDRESS: STREET 1: 14785 OMICRON DR SUITE 101 CITY: SAN ANTONIO STATE: TX ZIP: 78245 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ADVENT INTERNATIONAL CORP ET AL CENTRAL INDEX KEY: 0000939424 STANDARD INDUSTRIAL CLASSIFICATION: [] IRS NUMBER: 042840139 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 101 FEDERAL STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 6179519400 MAIL ADDRESS: STREET 1: 101 FEDERAL STREET CITY: BOSTON STATE: MA ZIP: 02110 SC 13G/A 1 ADVENT INTERNATIONAL CORPORATION 1 CUSIP NO. 451923-10-6 Schedule 13G/A Page 1 of 16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (RULE 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 2)(1) ILEX Oncology, Inc. (Name of issuer) Common Stock, par value $0.01 (Title of class of securities) 451923-10-6 (CUSIP number) July 16, 1999 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: / / Rule 13d-1(b) /X/ Rule 13d-1(c) / / Rule 13d-1(d) (Continued on the following pages) (Page 1 of 16 Pages) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). 2 CUSIP NO. 451923-10-6 Schedule 13G/A Page 2 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent International Corporation 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 1,454,689 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 1,454,689 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,454,689 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.4% 12 TYPE OF REPORTING PERSON* CO, IA SEE INSTRUCTIONS BEFORE FILLING OUT! 3 CUSIP NO. 451923-10-6 Schedule 13G/A Page 3 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent International Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 1,433,908 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 1,433,908 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,433,908 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 8.3% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 4 CUSIP NO. 451923-10-6 Schedule 13G/A Page 4 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent Health Care & Life Sciences II Verwaltungs GmbH 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF 5 SOLE VOTING POWER SHARES 58,894 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 58,894 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 58,894 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.3% 12 TYPE OF REPORTING PERSON* 00 SEE INSTRUCTIONS BEFORE FILLING OUT! 5 CUSIP NO. 451923-10-6 Schedule 13G/A Page 5 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent Health Care & Life Sciences II Beteilligung GmbH & Co. KG 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF 5 SOLE VOTING POWER SHARES 58,894 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 58,894 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 58,894 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.3% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 6 CUSIP NO. 451923-10-6 Schedule 13G/A Page 6 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Adventact Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 86,096 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 86,096 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 86,096 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.5% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 7 CUSIP NO. 451923-10-6 Schedule 13G/A Page 7 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent Health Care & Life Sciences II Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 757,974 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 757,974 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 757,974 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 4.4% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 8 CUSIP NO. 451923-10-6 Schedule 13G/A Page 8 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent Performance Materials Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 172,191 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 172,191 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 172,191 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.0% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 9 CUSIP NO. 451923-10-6 Schedule 13G/A Page 9 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Rovent II Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 358,753 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 358,753 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 358,753 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 2.1% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 10 CUSIP NO. 451923-10-6 Schedule 13G/A Page 10 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent International Investors II Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Massachusetts NUMBER OF 5 SOLE VOTING POWER SHARES 1,428 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 1,428 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,428 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 11 CUSIP NO. 451923-10-6 Schedule 13G/A Page 11 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent Partners HLS II Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 16,844 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 16,844 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 16,844 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.1% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 12 CUSIP NO. 451923-10-6 Schedule 13G/A Page 12 of 16 1 NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY) Advent Partners Limited Partnership 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) /X/ (b) / / 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5 SOLE VOTING POWER SHARES 2,509 BENEFICIALLY 6 SHARED VOTING POWER 0 OWNED BY 7 SOLE DISPOSITIVE POWER EACH REPORTING PERSON 2,509 WITH 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,509 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES / / 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.0% 12 TYPE OF REPORTING PERSON* PN SEE INSTRUCTIONS BEFORE FILLING OUT! 13 CUSIP NO. 451923-10-6 Schedule 13G/A Page 13 of 16 Item 1. (a) (b) This statement on Schedule 13G relates to the Reporting Persons' (as defined in Item 2 below) beneficial ownership interest in ILEX Oncology, Inc. a Delaware corporation (the "Corporation"). The address of the principal executive office of the Corporation is 11550 I.H. 10 West, Suite 300, San Antonio, Texas 78230. Item 2. (a) (b) (c) This statement is being filed by the following entities: (1) Advent International Corporation, a Delaware corporation; (2) Advent International Limited Partnership, a Delaware limited partnership; (3) Rovent II Limited Partnership; a Delaware limited partnership; (4) Advent Performance Materials Limited Partnership; a Delaware limited partnership; (5) Advent International Investors II Limited Partnership, a Massachusetts limited partnership; (6) AdventAct Limited Partnership, a Delaware limited partnership; (7) Advent Health Care and Life Sciences II Beteiligung GmbH and Co. KG, a German limited partnership; (8) Advent Health Care and Life Sciences II Verwaltungs GmbH, a German company; (9) Advent Health Care & Life Sciences II Limited Partnership, a Delaware limited partnership; (10) Advent Partners HLS II Limited Partnership, a Delaware limited partnership; (11) Advent Partners Limited Partnership, a Delaware limited partnership; The entities listed in subparagraph (1) through (11) above are herein collectively referred to as the "Reporting Persons" and individually as a "Reporting Person." The principal business address of all of the Reporting Persons is c/o Advent International Corporation, 75 State Street, Boston, MA 02109. (d) (e) This statement relates to the Common Stock, par value $0.01 per share, (the "Common Stock") of the Corporation named in Item 1 of this statement. The CUSIP number associated with such Common Stock is 451923-10-6. 14 CUSIP NO. 451923-10-6 Schedule 13G/A Page 14 of 16 Item 3. Filing pursuant to Rule 13d-1(b), or 13d-2(b) or (c). This statement is not being filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c). This statement is being filed pursuant to rule 13d-1(c). Item 4. Ownership. (a) (b) The following table sets forth the aggregate number and percentage (base upon the number of shares of Common Stock outstanding as of November 16, 1999) of the Common Stock beneficially owned by each Reporting Person named in Item 2 of this statement. The aggregate number and percentage of the Common Stock beneficially owned by each Reporting Person is calculated in accordance with Rule 13d-3(d)(1).
Number of Shares --------------------------------------- Percentage Under of Shares Reporting Person Common Warrants Total Outstanding - ---------------- ------ -------- ----- ----------- Advent Health Care & Life Sciences II Beteiligung GmbH & Co. KG (1) 58,894 0 58,894 0.3% --------- --------- --------- --- Advent Health Care & Life Sciences II Verwaltungs GmbH (1) 58,894 0 58,894 0.3% Adventact Limited Partnership (2) 83,149 2,947 86,096 0.5% Advent Health Care & Life Sciences II Limited Partnership (2) 757,974 0 757,974 4.4% Advent Performance Materials Limited Partnership (2) 166,298 5,893 172,191 1.0% Rovent II Limited Partnership (2) 344,080 14,673 358,753 2.1% --------- --------- --------- --- Advent International Limited Partnership (1), (2) 1,410,395 23,513 1,433,908 8.3% Advent International Investors II Limited Partnership (3) 1,428 0 1,428 0.0% Advent Partners HLS II Limited Partnership (3) 16,844 0 16,844 0.1% Advent Partners Limited Partnership (3) 2,509 0 2,509 0.0% --------- --------- --------- --- Advent International Corporation(1),(2),(3) 1,431,176 23,513 1,454,689 8.4% ========= ========= ========= === Total Group 1,431,176 23,513 1,454,689 8.4% ========= ========= ========= ===
(1) Advent International Corporation ("AIC") is the General Partner of Advent International Limited Partnership ("AILP") which in turn is the managing general partner of Advent Health Care & Life Sciences II Verwaltungs GmbH ("GmbH"), the general partner of Advent Health Care & Life Sciences II Beteiligung GmbH & Co. KG. ("GmbH KG") As such, AIC has the sole power to vote and dispose of the securities owned by the indicated reporting persons. The beneficial ownership of AIC, AILP, and GmbH derive from such power. (2) Advent International Corporation ("AIC") is the General Partner of Advent International Limited Partnership ("AILP") which in turn is the General Partner of the indicated Reporting Persons. As such, AIC has the sole power to vote and dispose of the securities owned by the indicated Reporting Persons. The beneficial ownership of AIC and AILP derive from such power. 15 CUSIP NO. 451923-10-6 Schedule 13G/A Page 15 of 16 (2) AIC is the General Partner of the indicated Reporting Person. As such, AIC has the power to vote and dispose of the securities of the Reporting Persons. The beneficial ownership of AIC derives from such power. (c) Each of the Reporting Persons listed in the table set forth above has sole voting and dispositive power over the Common Stock beneficially owned by it as indicated above. Item 5. Ownership of Five Percent or Less of a Class. Not Applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. Not Applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not Applicable. Item 8. Identification and Classification of Members of the Group. The information for this item is contained on the individual cover pages to this filing, and is incorporated herein by reference. Item 9. Notice of Dissolution of Group. Not Applicable. Item 10. Certification. By signing below we certify that, to the best of our knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. 16 CUSIP NO. 451923-10-6 Schedule 13G/A Page 16 of 16 SIGNATURE After reasonable inquiry and to the best of our knowledge and belief, we certify that the information set forth in this statement is true, complete and correct. February 14, 2000 ADVENT HEALTH CARE & LIFE SCIENCES II BETEILIGUNG GMBH & CO. KG By: Advent Health Care & Life Sciences II Verwaltungs GmbH, General Partner By: Advent International Limited Partnership, Managing General Partner By: Advent International Corporation, General Partner By: Janet L. Hennessy, Vice President* - ------------------------------------------- ADVENTACT LIMITED PARTNERSHIP ADVENT HEALTH CARE & LIFE SCIENCES II LIMITED PARTNERSHIP ADVENT PERFORMANCE MATERIALS LIMITED PARTNERSHIP ROVENT II LIMITED PARTNERSHIP By: Advent International Limited Partnership, General Partner By: Advent International Corporation, General Partner By: Janet L. Hennessy, Vice President* - ------------------------------------------- ADVENT INTERNATIONAL INVESTORS II LIMITED PARTNERSHIP ADVENT PARTNERS HLS II LIMITED PARTNERSHIP ADVENT PARTNERS LIMITED PARTNERSHIP By: Advent International Corporation, General Partner By: Janet L. Hennessy, Vice President* ADVENT INTERNATIONAL LIMITED PARTNERSHIP By: Advent International Corporation, General Partner By: Janet L. Hennessy, Vice President* ADVENT INTERNATIONAL CORPORATION By: Janet L. Hennessy, Vice President* *For all of the above - ------------------------------------------- By: Janet L. Hennessy, Vice President /s/ Janet L. Hennessy - ------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----